LM
AH

Litespeed Management’s Accretive Health AH Stock Holding History

Litespeed Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,476,021
Closed -$8.95M – 24
2016
Q2 		$8.95M Buy
4,476,021
+679,000
+18% +$1.36M 1.73% 16
2016
Q1 		$9.68M Buy
3,797,021
+999,378
+36% +$2.55M 1.89% 15
2015
Q4 		$8.95M Buy
+2,797,643
New +$8.95M 1.31% 16

Other funds holding AH

PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $443M AUM 46.78% 1-Year Est. Return

Litespeed Management's AH Position: Q3 2016 in Review

Litespeed Management sold out of Accretive Health (AH) in Q3 2016, closing a stake of 4,476,021 shares — an estimated $8.95M sold.

Litespeed Management first reported a position in AH in Q4 2015 and held it in 3 quarters. The position peaked at $9.68M in Q1 2016. 6 funds tracked by Wall St. Rank hold AH as of Q3 2016.

  • Litespeed Management reported no remaining Accretive Health position as of Q3 2016 after selling out during the quarter.
  • Litespeed Management sold 4,476,021 Accretive Health shares in Q3 2016, an estimated $8.95M.
  • Litespeed Management first reported a position in Accretive Health in Q4 2015 and held it in 3 quarters.
  • Litespeed Management's Accretive Health position peaked at $9.68M in Q1 2016.
  • 6 funds tracked by Wall St. Rank held Accretive Health as of Q3 2016.

Based on Litespeed Management's 13F filing for Q3 2016, filed 14 Nov 2016.